Table 3.
Baseline characteristics
| Patient | Urinary protein [g/day] | Age at biopsy [years] | Sex | Duration of disease [weeks] | Current therapy | Serum albumin [g/L] |
Serum creatinine [μmol/L] |
Diabetes | Follow-up |
|---|---|---|---|---|---|---|---|---|---|
| MCD1 | 10.66 | 41 | male | 3 | none | 21.7 | 76.6 | no | glucocorticoid-sensitive |
| MCD2 | 8.65 | 25 | female | 3 | none | 18.9 | 79.3 | no | glucocorticoid-resistant |
| MCD3 | 9.86 | 39 | male | 1 | none | 20.4 | 88 | no | glucocorticoid-sensitive |
| FSGS1 | 11.72 | 27 | male | 3 | Huangkui capsule | 24.8 | 82.4 | no | glucocorticoid-sensitive |
| FSGS2 | 9.72 | 23 | male | 2 | Huangkui capsule | 18.5 | 83 | no | glucocorticoid-resistant |
| FSGS3 | 9.26 | 42 | female | 2 | none | 19.2 | 67.8 | no | glucocorticoid-sensitive |